Swayamjeet Satapathy

10PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsGene and molecular therapyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 07, 2026
68Ga-PSMA-11 PET/CT Versus Conventional Imaging for Response Evaluation in Metastatic Castration-resistant Prostate Cancer: A Single-center Prospective Study.

Komal Preet, Ashwani Sood, Swayamjeet Satapathy

|Sep 29, 2025
Radioiodine Plus Low-Dose Lenvatinib in Radioiodine-Sensitive High-Volume Metastatic Differentiated Thyroid Cancer: A Pilot Study.

Chandra Teja Reddy Singareddy, Chandrasekhar Bal, Swayamjeet Satapathy

|May 25, 2025
Novel framework for response evaluation criteria in grade 1/2 neuroendocrine tumors (RECIN) following [177Lu]Lu-DOTATATE therapy: post-hoc analysis of the phase 2 LuCAP trial.

Swayamjeet Satapathy, Piyush Aggarwal, Ashwani Sood

|May 20, 2025
Safety and Efficacy of Peptide Receptor Radionuclide Therapy in Multiple Endocrine Neoplasia Syndrome: A Single-center Experience.

Piyush Aggarwal, Swayamjeet Satapathy, Gurjeet Kaur

|Mar 11, 2025
PSMA-based Theranostics in Advanced Non-small Cell Lung Cancer: A Hit or a Miss?

Piyush Aggarwal, Anupriya Anwariya, Komalpreet Kaur

|Jan 23, 2025
Utility of Novel Radiohybrid PSMA Ligands in PET Imaging of Biochemical Recurrence of Prostate Cancer-A Systematic Review and Meta-analysis.

Kunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal

Pageof 2

Frequent Collaborators

3 joint publications

Ashwani Sood

2 joint publications

Chandrasekhar Bal

2 joint publications

Piyush Aggarwal

2 joint publications

Bhagwant Rai Mittal